Intersect ENT
Why Robinhood?
You can watch Intersect ENT and buy or sell other stocks, ETFs, and their options commission-free!About XENT
Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA.
XENT Key Statistics
Stock Snapshot
The current Intersect ENT(XENT) stock price is $28.24, with a market capitalization of 954.9M. The stock trades at a price-to-earnings (P/E) ratio of -5.63.
On 2026-03-01, Intersect ENT(XENT) stock opened at —, reached a high of —, and a low of —.
The Intersect ENT(XENT)'s current trading volume is 0, compared to an average daily volume of 733.84K.
In the last year, Intersect ENT(XENT) shares hit a 52-week high of $28.25 and a 52-week low of $15.92.
In the last year, Intersect ENT(XENT) shares hit a 52-week high of $28.25 and a 52-week low of $15.92.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.